LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis -

Applications | 2017 | ShimadzuInstrumentation

LC/MS, LC/MS/MS, LC/QQQ

Industries

Pharma & Biopharma

Manufacturer

Shimadzu

Go to the library View PDF

Downloadable PDF for viewing

Similar PDF

LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis -

2017|Shimadzu|Applications

LAAN-A-LM-E118A Application News No. C147A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that…

Key words

nivolumab, nsmol, antibody, structure, nsmoltm, accuracy, peptides, confirmation, immunological, drugs, validation, average, quantitation, immune, bioanalysis

LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis -

2017|Shimadzu|Applications

LAAN-A-LM-E116B Application News No. C145B nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that enables selective proteolysis…